Serum osteocalcin levels in hyperthyroidism before and after antithyroid therapy

Tohoku Journal of Experimental Medicine

Volumn 203, Issue 3, 2004, Pages 183-188

  Barsal, Gulhan ^b   Taneli, Fatma ^a   Atay, Ayşenur ^b   Hekimsoy, Zeliha ^a   Erciyas, Fusun ^b  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Bone turnover; Hyperthyroidism; Osteocalcin

Indexed keywords

ALKALINE PHOSPHATASE; ANTITHYROID AGENT; BIOCHEMICAL MARKER; CALCIUM ION; CREATININE; LIOTHYRONINE; OSTEOCALCIN; PHOSPHORUS; PROPYLTHIOURACIL; THYROTROPIN; THYROXINE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BONE REMODELING; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; DISEASE MARKER; EUTHYROIDISM; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; MALE; MEDICAL DOCUMENTATION; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; THYROTROPIN BLOOD LEVEL; URINALYSIS;

ALKALINE PHOSPHATASE; ANTITHYROID AGENTS; BIOLOGICAL MARKERS; BONE RESORPTION; CALCIUM; CASE-CONTROL STUDIES; CREATININE; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; OSTEOCALCIN; PHOSPHORUS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 4444332923     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.203.183     Document Type: Article

References (22)

1. Abu, E.O., Bord, S., Horner, A., Chatterjee, U.K. & Compston, J.E. (1997) The expression of thyroid hormone receptor in human bone. Bone, 21, 137-142.
2. Akalin, A., Colak, O., Alatas, O. & Efe, B. (2002) Bone remodeling markers and serum cytokines in patients with hyperthyroidism. Clin. Endocrinol. (Oxf), 57, 125-129.
3. Burtis, C.A. & Edward R.A. (1999) Tietz Textbook of Clinical Chemistry, 3rd ed., W.B. Saunders Company, Philadelphia, Pennnsylvania, USA, pp. 1404-1408.
4. Cooper, D.S., Kaplan, M.M., Ridway, E.C., Maloof, F. & Daniels, G.H. (1979) Alkaline phosphatase isoenzyme patterns in hyperthyroidism. Ann. Intern. Med., 90, 164-168.
5. Engler, H., Oettli, R.E. & Riesen, W.F. (1999) Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study. Clin. Chim. Acta, 289, 159-172.
6. Garrel, D.R., Delmas, P.D., Malaval, L. & Tourniaire, J. (1986) Serum bone gla protein: a marker of bone turnover in hyperthyroidism. J. Clin. Endocrinol. Metab., 62, 1052-1055.
7. Gundberg, C.M., Markowittz, M.E., Mizruchi, M. & Rosen, J.F. (1985) Osteocalcin in human serum: A circadian rhythm. J. Clin. Endokrinol. Metab., 60, 736-739.
8. Isaia, G.C., Roggia, C., Gola, D., Stefano, M.D., Gallone, G., Aimo, G., Ardissone, P. & Mmusetta, M. (2000) Bone turnover in hyperthyroidism before and after thyrostatic management. J. Endocrinol. Invest., 23, 727-731.
9. Jodar, E., Martinez-Diaz-Guerra, G., Azriel, S. & Hawkins, F. (2001) Bone mineral density in male patients with L-thyroxine suppressive therapy and Graves disease. Calcif. Tissue Int., 69, 84-87.
10. Kisakol, G., Kaya, A., Gonen, S. & Tunc, R. (2003) Bone and calcium metabolism in subclinical autoimmune hyperthyroidism and hypothyroidism. Endocr. J., 50, 657-661.
11. Kobe, N., Takamatsu, J., Ito, M., Sakane, S. & Ohsawa, N. (1999) Acute and early effects of triiodothyronine administration on serum markers of bone and mineral metabolism. Endocrine, 10, 53-56.
12. Leon Sanz, M., Hawkins, F., Larrodera, L., Sarabia, F. & Schuller, A. (1990) Serum osteocalcin and bone turnover in hyperthyroidism. Rev. Clin. Esp., 186, 155-158.
13. Meunier, P.J. (1995) Hyperthyroidism and osteoporosis. Ann. Endocrinol., 56, 57-59.
14. Mosekilde, L., Eriksen, E.F. & Charles, P. (1990) Effects of thyroid hormones on bone and mineral metabolism. Endocrinol. Metab. Clin. North Am., 19, 35-63.
15. Pandolfi, C., Montarini, G., Mercantini, F. & Sbalzarini, G. (1992) Osteocalcin and hyperthyroidism. Minerva Endocrinol., 17, 75-78.
16. Pantazi, H. & Papapetrou, P.D. (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J. Clin. Endoc. Metab., 85, 1099-1106.
17. Rizzoli, R., Poser, J. & Bürgi, U. (1986) Nuclear Thyroid hormone receptors in cultured bone cells. Metabolism, 35, 71-74.
18. Roiter, I., Legovini, P., Da, Rin, G., Galliazzo, S., Di Virligilio, R., Foscolo, G. Breda, F. & Conte, N. (1990) Serum osteocalcin in hyperthyroidism. Ann. Ital. Med. Int., 5, 95-99.
19. Rosen, C.J. & Adler, R.A. (1992) Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J. Clin. Endocrinol. Metab., 75, 1531-1534.
20. Ross, D.S., Ardisson, L.J., Nussbaum, S.R. & Meskell, M.J. (1991) Serum osteocalcin in patients taking L-throxine who have subclinical hyperthyroidism. J. Clin. Endocrinol. Metab., 72, 507-509.
21. Siddiqi, A., Burrin, J.M., Noonan, K., James, I., Wood, D.F., Price, C.P. & Monson, J.P. (1997) A Longitudinal study of markers of bone turnover in Graves' disease and their value in predicting bone mineral density. J. Clin. Endocrinol. Metab., 82, 753-759.
22. Vamos, M.J. & Balazs, C. (1997) Bone metabolism markers in patients with Basedow-Graves disease. Orv. Hetil., 138, 2403-2405.